Daniel Li

6.4k total citations · 2 hit papers
63 papers, 2.3k citations indexed

About

Daniel Li is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Daniel Li has authored 63 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Genetics and 12 papers in Immunology. Recurrent topics in Daniel Li's work include CAR-T cell therapy research (16 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Systemic Lupus Erythematosus Research (5 papers). Daniel Li is often cited by papers focused on CAR-T cell therapy research (16 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Systemic Lupus Erythematosus Research (5 papers). Daniel Li collaborates with scholars based in United States, Canada and Germany. Daniel Li's co-authors include Richard R. Furman, Steven Coutré, Jennifer R. Brown, John C. Byrd, David G. Maloney, Stanley R. Riddell, Cameron J. Turtle, Shelly Heimfeld, Laïla‐Aïcha Hanafi and Brent L. Wood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Daniel Li

60 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib

2017 485 citations Cameron J. Turtle, Laïla‐Aïcha Hanafi et al. profile →
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia

2014 465 citations Daniel Li et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Li United States	20	996	867	650	524	508	63	2.3k
Mazyar Shadman United States	25	1.4k 1.4×	669 0.8×	1.0k 1.6×	318 0.6×	405 0.8×	221	2.3k
Jun Zhu China	24	1.4k 1.5×	558 0.6×	1.3k 2.1×	479 0.9×	552 1.1×	177	2.5k
Samantha Jaglowski United States	24	940 0.9×	1.5k 1.7×	1.2k 1.8×	466 0.9×	896 1.8×	152	2.9k
Julio Delgado Spain	35	1.0k 1.0×	1.6k 1.9×	1.3k 2.1×	647 1.2×	939 1.8×	195	3.6k
Lloyd E. Damon United States	27	932 0.9×	970 1.1×	893 1.4×	781 1.5×	375 0.7×	110	3.8k
Alex McMillan United States	33	944 0.9×	478 0.6×	542 0.8×	861 1.6×	359 0.7×	57	3.5k
Jacques‐Olivier Bay France	25	721 0.7×	386 0.4×	290 0.4×	702 1.3×	391 0.8×	151	2.4k
Vincenzo Tombolini Italy	36	1.5k 1.5×	341 0.4×	318 0.5×	1.1k 2.0×	180 0.4×	224	4.4k
Andreas Trojan Switzerland	22	741 0.7×	206 0.2×	214 0.3×	339 0.6×	567 1.1×	64	1.8k
Michael L. Grossbard United States	37	2.3k 2.3×	859 1.0×	1.8k 2.8×	648 1.2×	828 1.6×	120	4.7k

Countries citing papers authored by Daniel Li

Since Specialization

Citations

This map shows the geographic impact of Daniel Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Li more than expected).

Fields of papers citing papers by Daniel Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Li. The network helps show where Daniel Li may publish in the future.

Co-authorship network of co-authors of Daniel Li

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Li. A scholar is included among the top collaborators of Daniel Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Li. Daniel Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Velez, Maria A., Andy Han, Daniel Li, et al.. (2025). Adequacy of Immune Checkpoint Inhibitor–Associated Thyroid Function Monitoring After Therapy. JCO Oncology Practice. 22(2). 306–313. 1 indexed citations

Li, Daniel, B. Douglas Smith, Mark J. Levis, et al.. (2024). Efficacy and Tolerability of Blinatumomab in Clinical Trial Ineligible Patients with CD19+ Leukemias. Blood. 144(Supplement 1). 5904–5904.

Cao, Sheng, Yibin Wang, Daniel Li, & Xiaohua Peng. (2023). H₂O₂‐Inducible DNA Cross‐linking Agents Capable of Releasing Multiple DNA Alkylators as Anticancer Prodrugs. ChemMedChem. 18(19). e202300273–e202300273. 5 indexed citations

Li, Daniel, et al.. (2023). Harnessing In Situ Simulation to Identify Human Errors and Latent Safety Threats in Adult Tracheostomy Care. The Joint Commission Journal on Quality and Patient Safety. 50(4). 279–284. 3 indexed citations

Li, Daniel, Jeffrey E. Segall, Michael B. Prystowsky, et al.. (2021). Palbociclib Renders Human Papilloma Virus–Negative Head and Neck Squamous Cell Carcinoma Vulnerable to the Senolytic Agent Navitoclax. Molecular Cancer Research. 19(5). 862–873. 22 indexed citations

Li, Daniel, Meide Zhao, Xinjian Du, et al.. (2021). Patient-Specific Cerebral Flow Model Using Regional Flows and Multi-Objective Optimization. Journal of Neurology Research. 11. 37–46.

Safavi, Shahideh, Brandon Zanette, Ruixue Dai, et al.. (2021). Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study. Respiratory Medicine. 180. 106368–106368. 11 indexed citations

Weskamp, Gisela, Johanna Tüshaus, Daniel Li, et al.. (2020). ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1). Journal of Biological Chemistry. 295(13). 4350–4358. 20 indexed citations

Keenan, Tiarnán D L, Qingyu Chen, Yifan Peng, et al.. (2020). Deep learning automated detection of reticular pseudodrusen from fundus autofluorescence images and color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2). Investigative Ophthalmology & Visual Science. 61(7). 1644–1644. 1 indexed citations

10.

Cadnum, Jennifer L., et al.. (2020). Effectiveness of Ultraviolet-C Light and a High-Level Disinfection Cabinet for Decontamination of N95 Respirators. SHILAP Revista de lepidopterología. 5(1). 52–52. 90 indexed citations

11.

Speyer, Cameron B., Daniel Li, Hongshu Guan, et al.. (2019). Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores. Rheumatology International. 40(2). 257–261. 21 indexed citations

12.

Finney, Olivia, Hannah Brakke, Stephanie Rawlings-Rhea, et al.. (2019). CD19 CAR T cell product and disease attributes predict leukemia remission durability. Journal of Clinical Investigation. 129(5). 2123–2132. 244 indexed citations

13.

Li, Daniel, et al.. (2019). Spectralis OCT1 versus OCT2: Time Efficiency and Image Quality of Retinal Nerve Fiber Layer Thickness and Bruch\'s Membrane Opening Analysis for Glaucoma Patients. JOURNAL OF CURRENT GLAUCOMA PRACTICE. 13(1). 16–20. 7 indexed citations

14.

Santomasso, Bianca, Jae Hong Park, Isabelle Rivière, et al.. (2018). Neurotoxicity Associated with CD19-specific Chimeric Antigen Receptor T cell Therapy for Adult Acute Lymphoblastic Leukemia (B-ALL) (S23.008). Neurology. 90(15_supplement). 3 indexed citations

15.

Swanson, Christina, Trevor Do, Claire L. Sutherland, et al.. (2017). Predicting Clinical Response and Safety of JCAR017 in B-NHL Patients: Potential Importance of Tumor Microenvironment Biomarkers and CAR T-Cell Tumor Infiltration. Blood. 130. 194–194. 6 indexed citations

16.

Turtle, Cameron J., Laïla‐Aïcha Hanafi, Daniel Li, et al.. (2016). CD19 CAR-T Cells Are Highly Effective in Ibrutinib-Refractory Chronic Lymphocytic Leukemia. Blood. 128(22). 56–56. 12 indexed citations

17.

García-Posadas, Laura, Robin R. Hodges, Daniel Li, et al.. (2015). Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function. Mucosal Immunology. 9(1). 206–217. 54 indexed citations

18.

Li, Daniel, Robin R. Hodges, Jianwei Jiao, et al.. (2013). Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. Mucosal Immunology. 6(6). 1119–1130. 75 indexed citations

19.

Li, Daniel, Matthew P. Longnecker, & David B. Dunson. (2013). Lipid Adjustment for Chemical Exposures. Epidemiology. 24(6). 921–928. 17 indexed citations

20.

Li, Daniel, et al.. (2011). Kim Moodie : All But Not. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact